pharma news today glp-1 today India's fast-growing weight-loss drug market is showing signs of moderation after a sharp surge in recent months. New data reveals that sales growth of semaglutide and therapies slowed BIG PHARMA NEWS: 7 GLP-1

Book now to accelerate your jo Book Now AOD-9604 Peptide (10 mg vial) designed for fat metabolism and weight management

FeelGood GLP-1 2026 Research Explores Brand-Stated $149/Month Telehealth Access, Compounded Medication Disclosures, and Buyer Questions Why This Review Exists Right Now - and Why Timing Matters for GLP-1 Buyers in 2026 FDA has publicly identified concerns involving unapproved and compounded GLP-1 products, including dosing errors, improper storage during shipping, fraudulent compounded products, adverse-event reports, semaglutide salt forms, and illegal online sales

The site is updated occasionally, but may not reflect the most up-to-date information

A substance which initiates a physiological response when combined with a receptor

Recent landmark studies revealed that semaglutide and tirzepatide reduce major adverse cardiac events by 20 to 25 percent, positioning GLP-1 medications as genuine preventive health tools rather than cosmetic interventions

Presented for research literature review only U-Din M et al